BIOGEN INC. (BIIB) FY2025 Annual Balance Sheet
As of 2025-12-31
Balance Sheet
As of 2025-12-31
Swipe to see the full flow
Chart details
BIOGEN INC. (BIIB) FY2025 Annual Balance Sheet
Balance sheet as of 2025-12-31. The chart shows assets, liabilities and equity at that date.
- Assets
- 29,439,500,000 US dollars
- Current assets
- 8,974,100,000 US dollars
- Non-current assets
- 20,465,400,000 US dollars
- Liabilities
- 11,182,700,000 US dollars
- Current liabilities
- 3,349,400,000 US dollars
- Non-current liabilities
- 7,833,300,000 US dollars
- Equity
- 18,256,800,000 US dollars
- Cash and cash equivalents
- 3,008,500,000 US dollars
- Inventory
- 2,168,100,000 US dollars
- Accounts receivable, net of allowance for doubtful accounts of $3.0 and $2.2, respectively
- 1,342,400,000 US dollars
- Other current assets
- 1,123,300,000 US dollars
- Current portion of marketable securities
- 807,200,000 US dollars
- Due from anti-CD20 therapeutic programs
- 524,600,000 US dollars
- Intangible assets, net
- 9,178,500,000 US dollars
- Goodwill
- 6,491,100,000 US dollars
- Property, plant and equipment, net
- 3,055,400,000 US dollars
- Investments and other assets
- 750,600,000 US dollars
- Marketable securities
- 431,900,000 US dollars
- Deferred tax asset
- 292,500,000 US dollars
- Operating lease assets
- 265,400,000 US dollars
- Accrued expense and other
- 2,802,600,000 US dollars
- Accounts payable
- 432,000,000 US dollars
- Taxes payable
- 114,800,000 US dollars
- Current portion of notes payable
- 0 US dollars
- Notes payable
- 6,286,800,000 US dollars
- Other long-term liabilities
- 748,500,000 US dollars
- Deferred tax liability
- 507,600,000 US dollars
- Long-term operating lease liabilities
- 290,400,000 US dollars
- Retained earnings
- 20,552,700,000 US dollars
- Additional paid-in capital
- 863,100,000 US dollars
- Common stock, par value $0.0005 per share
- 100,000 US dollars
- Preferred stock, par value $0.001 per share
- 0 US dollars
- Treasury stock, at cost; 23.8 million and 23.8 million shares, respectively
- negative 2,977,100,000 US dollars
- Accumulated other comprehensive income (loss)
- negative 182,000,000 US dollars
- Gross equity (calculated)
- 21,415,900,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
